首页>
外国专利>
CD20-SPECIFIC REDIRECTED T CELLS AND THEIR USE IN CELLULAR IMMUNOTHERAPY OF CD20+ MALIGNANCIES
CD20-SPECIFIC REDIRECTED T CELLS AND THEIR USE IN CELLULAR IMMUNOTHERAPY OF CD20+ MALIGNANCIES
展开▼
机译:CD20特异性重定向的T细胞及其在CD20 +恶性肿瘤细胞免疫治疗中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Genetically engineered, CD20-specific redirected T cells expressing a cell surface protein having an extracellular domain comprising a receptor which is specific for CD20, an intracellular signaling domain, and a transmembrane domain. Use of such cells for cellular immunotherapy of CD20+ malignancies and for abrogating any untoward B cell function. In one embodiment, the cell surface protein is a single chain FvFc: zeta receptor where Fv designates the VH and VL chains of a single chain monoclonal antibody to CD20 linked by peptide, Fc represents a hinge-CH2-CH3 region of a human IgG1, and zeta represents the intracellular signaling domain of the zeta chain of human CD3. A method of making a redirected T cell expressing a chimeric T cell receptor by electroporation using naked DNA encoding the receptor.
展开▼